SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,812.03 -452.48
( -0.59%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-11.5421201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

213.69

EPS(TTM)

Face Value()

Div & Yield %

Back

BCL Industries consolidated net profit rises 5.29% in the June 2026 quarter

Aug 12,2026

Net profit of BCL Industries rose 5.29% to Rs 32.25 crore in the quarter ended June 2026 as against Rs 30.63 crore during the previous quarter ended June 2025. Sales declined 26.36% to Rs 583.19 crore in the quarter ended June 2026 as against Rs 791.95 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	583.19	791.95	-26
OPM %	10.48	6.75	-
PBDT	61.21	49.21	24
PBT	46.82	37.75	24
NP	32.25	30.63	5

76,812.03 -452.48 ( -0.59%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)